Seek more insights? Subscribe to our Monthly Newsletter
UK HealthTech start-ups ease pressures on public and private healthcare providers by incorporating innovative technologies in healthcare. Case in point: UK Improvement Analytics Unit analysis showed that only 10% of patients prefer face-to-face GP consultation in 2022. Other 90% opt for virtual meetings. These innovations are possible thanks to significant investments in the HealthTech sector: UK HealthTech investment has grown from £345m in 2016 to £3.13b in 2021. Moreover, seven of the UK’s unicorn companies operate in the HealthTech industry. Another aspect that can further boost the sector is the UK Innovator Founder Visa. Introduced in April 2023, this initiative opens doors for individuals with groundbreaking HealthTech ideas to come to the UK and start innovative businesses.
This article discusses the opportunities within the UK’s HealthTech sector for potential UK Innovator Founder Visa applicants. The article begins by describing HealthTech and its landscape in the UK. Then, we discuss opportunities and challenges in the UK HealthTech sector. Lastly, the article provides a detailed overview of the UK Innovator Founder visa and crafting a HealthTech business plan.
Current State of HealthTech Industry in the UK
HealthTech, or Health Technology, is a field that innovates technology to improve healthcare delivery, patient care, and overall health outcomes. This rapidly growing sector integrates products, services, and systems, from electronic health records (EHRs) and telemedicine platforms to wearable health monitoring devices, mobile health applications, and advanced medical devices like robotic surgery systems. HealthTech’s goal is to make healthcare services more effective, accessible, and affordable.
In 2023, HealthTech continues to evolve, focusing on personalized care, remote healthcare, and the integration of advanced technologies like AI for predictive diagnostics and treatment planning. For instance, wearable technology such as smartwatches has become mainstream, enabling at-home health monitoring and data collection. Healthcare providers can later use this data for more personalized patient care. Additionally, the use of AI in healthcare is expanding, with applications ranging from clinical decision support systems to natural language processing tools for patient communication.
As of November 15, 2023, the UK has emerged as a leader in Europe’s HealthTech sector. To prove this point, in 2023, UK-based HealthTech start-ups have successfully raised $1.3 billion. In addition, this prominence is bolstered by the nation’s leading life sciences institutions and government initiatives focused on reducing long-term healthcare costs.
The UK intensively focuses on integrating technology into healthcare, particularly post-COVID-19. The pandemic placed immense pressure on the National Health Service (NHS), leading to a concerted effort to modernize healthcare through technology. Moreover, the country is home to four of the world’s top 25 life sciences universities, including Oxford and Cambridge, which further strengthens its position in the sector.
The Association of British HealthTech Industries reports that the UK, with its 4,300 health tech companies generating a combined turnover of about $37 billion, leads in investment over its European counterparts. This is evidenced by the surge in NHS App registrations from two million in 2021 to 30 million in 2023.
The health tech sector in the UK has experienced notable growth in employment and economic contribution. HealthTech, encompassing a broad range of technologies improving healthcare delivery and patient outcomes, has become the largest employer within the Life Sciences sector. The sector employs approximately 145,700 people across 4,300 companies, contributing significantly to the UK economy with a combined turnover of around £30 billion. The health tech sector’s growth rate has been around 5% in recent years, reflecting its expanding role in the healthcare system and its economic significance.
Opportunities in the UK Health Tech Sector
In 2024, virtual reality (VR) and mixed reality (MR) are increasingly being used in surgery. VR technologies are advancing graphical fidelity, user interaction, and scenario complexity, making medical simulations more nuanced and realistic. These technologies enable medical professionals to practice their skills in a safe environment, bridging the gap between theoretical knowledge and practical application.
The telemedicine and remote monitoring (RPM) sector is expanding in 2024. This growth is driven by the integration of telehealth with chronic and acute patient monitoring, advancements in wearable technology, and the growing adoption of Hospital-at-Home (HaH) initiatives. Remote patient monitoring is shifting towards more acute care, employing real-time sensors to create a comprehensive 24/7 patient picture. User-centric advancements focus on making technology more accessible and beneficial, especially for the elderly and those with health issues. Additionally, cardiology and oncology are key areas benefiting from RPM, with wearable devices helping to manage cardiac conditions and monitoring post-treatment effects in cancer patients.
The field of neurology is seeing increased investment in health tech startups focusing on neurological conditions in 2024. This investment is driven by the need for innovative solutions in diagnosing, monitoring, and treating various neurological disorders. Advances in technology, including AI and machine learning, are enabling more accurate and early detection of conditions such as Alzheimer’s, Parkinson’s, and multiple sclerosis. Wearable technology and mobile health apps are being developed to monitor symptoms and treatment responses in real time.
In 2024, interoperability in HealthTech is crucial for ensuring the seamless integration of digital tools with existing healthcare systems. This involves the effective communication and exchange of data between different healthcare information systems, devices, and applications. The goal is to create a more coordinated and efficient healthcare system, where patient information is easily accessible and can be shared securely among various healthcare providers. Interoperability enhances patient care by providing a comprehensive view of the patient’s health history, enabling better decision-making and reducing the likelihood of medical errors. Additionally, it supports the advancement of personalized medicine by facilitating the integration and analysis of large datasets, including genomic and clinical data. As the healthcare industry continues to embrace digital transformation, interoperability remains a key focus to ensure the effective use of technology in improving patient outcomes.
The healthcare sector, contributing up to 5% of global carbon emissions, faces the challenge of achieving sustainability. The NHS has set a goal to reach net zero by 2045, with similar plans in devolved nations, necessitating HealthTech providers to create Carbon Reduction Plans (CRPs). Initially targeting larger suppliers and small to medium-sized enterprises (SMEs) with contracts over £5M by April 2023, the requirement will extend to other SMEs by 2030, demanding published CRPs, targets, and annual reporting.
HealthTech innovation, though advancing, is costly and time-consuming, requiring substantial funding to bring new technologies to market. The link between regulation and funding is particularly strong, with investment often contingent on regulatory approval. This creates a situation where regulatory uncertainty leads to financial uncertainty. The majority of stakeholders identify funding as their primary challenge, even surpassing regulatory difficulties. The HealthTech Regulatory and Innovation Programme (HTRIP) has addressed this by providing grant support, indicating a need for regulatory support at all stages, including for commercialized products.
UK-based HealthTech SMEs traditionally target the NHS as their primary market. However, current challenges, including Brexit and the pandemic, prompted a shift. For instance, about 20% of SMEs now looking beyond the UK, especially digital/AI SMEs. Access to NHS innovation and adoption, engagement with clinicians and procurement, and navigating multiple decision-makers are key challenges. A strong domestic market is desirable for global credibility, but technical, regulatory, and funding challenges are influencing market selection, emphasizing the need to resolve these to clear the path to market.
A robust supply chain is crucial for manufacturing and distributing products. Disruptions in the supply chain can lead to significant revenue loss and market share reduction. HealthTech companies must ensure their supply chains meet expected demand and revenue projections. The importance of supply chain resilience has grown, with strategies like diversifying suppliers to mitigate future disruptions.
The demand for highly skilled workers is growing in the HealthTech sector, with a skills shortage in areas where recruitment demand exceeds the talent pool. This shortage is a significant challenge, as skilled workers are essential for driving industry innovation. HealthTech SMEs anticipate future skills gaps, particularly in software/AI/ML/app development, regulatory and quality, sales and marketing, and engineering. These gaps highlight the need for a comprehensive strategy to cultivate and attract the necessary talent to sustain industry growth.
Criterea for Obtaining the UK Innovator Founder Visa in HealthTech
If you know how to tackle the challenges in the UK HealthTech sector with a novel solution, the UK Innovator Founder Visa offers an opportunity to establish your business in the UK.
But before you apply for a visa, you should know the importance of a well-thought-out business plan. The business plan must reflect your idea’s potential for innovation, growth, and development. This comprehensive plan is not just a summary of your idea but a proof of your business’s ability to bring about significant change in the HealthTech sector. The strength and clarity of your business plan are crucial for securing an endorsement from an approved body, a key step in the visa application process.
Criteria for a HealthTech Business Plan
If your business plan meets these criteria, you will likely receive an endorsement from a UK-approved endorsing body. This endorsement signifies that your HealthTech business is not only viable but also an innovative and valuable addition to the UK’s dynamic HealthTech landscape. Securing this endorsement is vital for moving forward with the visa application process and establishing your innovative HealthTech business in the UK.
Tech Nomads is a global mobility platform that provides services in international relocation. Established in 2018, Tech Nomads has a track record of successfully relocating talents and teams. Our expertise in adapting to regulatory changes ensures our clients’ satisfaction and success.
To explore your UK relocation options, you may:
Subscribe to our social media platforms to stay up-to-date on global mobility news and opportunities: